| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |